Whittier Trust Co. Reduces Stake in IQVIA Holdings Inc.

The institutional investor sold over 20,000 shares of the medical research company in Q4 2025.

Apr. 18, 2026 at 12:22pm

A highly detailed, black-and-white close-up image of various financial and technological equipment, representing the complex machinery that underpins the medical research industry and investment strategies.An extreme close-up of the complex financial infrastructure that powers the medical research industry, hinting at the behind-the-scenes operations driving investment decisions.Whittier Today

Whittier Trust Co., a California-based institutional investor, decreased its stake in IQVIA Holdings Inc. (NYSE: IQV) by 54.6% during the fourth quarter of 2025, according to a recent SEC filing. The firm now owns 16,783 shares of the medical research company's stock, valued at $4.04 million.

Why it matters

This filing provides insight into the investment strategies of Whittier Trust Co., a prominent institutional investor. The significant reduction in their IQVIA holdings could signal a shift in their outlook on the medical research industry or the company's prospects.

The details

According to the SEC filing, Whittier Trust Co. sold 20,162 shares of IQVIA Holdings Inc. during the fourth quarter of 2025, reducing their total stake in the company to 16,783 shares. IQVIA is a global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry.

  • Whittier Trust Co. filed the 13F report disclosing the stake reduction on April 18, 2026.
  • The stake reduction occurred during the fourth quarter of 2025.

The players

Whittier Trust Co.

A California-based institutional investor that manages assets for high-net-worth individuals and families.

IQVIA Holdings Inc.

A global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry.

Got photos? Submit your photos here. ›

The takeaway

This filing highlights the shifting investment strategies of institutional investors like Whittier Trust Co. in the medical research industry. The significant reduction in their IQVIA holdings could signal broader trends or concerns within the sector that investors should monitor.